About us
Our expertise
Commercial >
We provide commercial consulting and advisory solutions across the product development and commercialization lifecycle.

Portfolio, Licensing & Development >

Commercialization & Growth >

Data Strategy & Analytics >

Value, Pricing & Access >
Our expertise across scientific and commercial domains delivers a collaborative and bespoke approach to maximize patient access and the commercial success of your innovations.

Value, Pricing & Access Strategy >

HEOR Evidence Generation >

Evidence Synthesis & RWE Generation >

Medical & Scientific Affairs >
We provide world-class thought partnership and solutions that enhance the business impact of medical and scientific affairs.

Asset Development >

Launch Strategy >

Digital Health & Omnichannel Strategy >

Centers of Excellence >
Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.

Advanced Clinical Technologies >

Forecasting & Financial Modeling >

Integrated Insights >
AI at Putnam

A strategic thought partner for your AI journey

Learn more
Join Putnam
Insights

Contact

Identifying micro-moments and how to leverage them

0 mins read

Blog, Commercial, Data Strategy & Analytics

Scroll

Insights

More insights.

See all insights

Medicare price negotiation: Putnam’s round two picks

Putnam predicts the 15 drugs likely to be selected for the second round of Medicare Price Negotiations.

Emerging trends in complement therapeutics

Putnam has a proven track record of delivering superior strategic support to pharma leaders in developing strategies...

Incorporating the preferences of patients with rare diseases in health technology assessment

Health technology assessments (HTAs) are a crucial part of the journey to bring newly developed pharmaceuticals and medical devices to patients.